Skip to Main content Skip to Navigation
Journal articles

Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides

Abstract : Ultra-small 1-2 nm gold nanoparticles (NP) were conjugated with a poorly-soluble peptide auto-antigen, associated with type 1 diabetes, to modify the peptide pharmacokinetics, following its intradermal delivery. Peptide distribution was characterized, in vivo, after delivery using either conventional intradermal injection or a hollow microneedle device. The poorly-soluble peptide was effectively presented in distant lymph nodes (LN), spleen and draining LN when conjugated to the nanoparticles, whereas peptide alone was only presented in the draining LN. By contrast, nanoparticle conjugation to a highly-soluble peptide did not enhance in vivo distribution. Transfer of both free peptide and peptide-NPs from the skin to LN was reduced in mice lacking lymphoid homing receptor CCR7, suggesting that both are actively transported by migrating dendritic cells to LN. Collectively, these data demonstrate that intradermally administered ultra-small gold nanoparticles can widen the distribution of poorly-soluble auto-antigenic peptides to multiple lymphoid organs, thus enhancing their use as potential therapeutics.
Document type :
Journal articles
Complete list of metadatas
Contributor : Bernard Malissen <>
Submitted on : Monday, November 23, 2020 - 3:20:01 PM
Last modification on : Tuesday, November 24, 2020 - 3:28:50 AM


Publication funded by an institution




R Singh, C. Malosse, J. Davies, Bernard Malissen, E. Kochba, et al.. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2020, ⟨10.1016/j.nano.2020.102321⟩. ⟨hal-03013467⟩



Record views


Files downloads